Indonesia Malaysia Philippines Thailand And Vietnam Iga Nephropathy Market Analysis

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Pharmaceutical Indonesia Malaysia Philippines Thailand And Vietnam Iga Nephropathy Market Market Analysis
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Indonesia Malaysia Philippines Thailand And Vietnam Iga Nephropathy Market Analysis

  • Pharmaceutical
  • Published Report
  • Jan 2024
  • Country Level
  • 350 Pages
  • No of Tables: 127
  • No of Figures: 37
Buy Now Buy Now

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF INDONESIA, MALAYSIA, THAILAND, PHILIPPINES & VIETNAM IGA NEPHROPATHY MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 YEARS CONSIDERED FOR THE STUDY

2.3 CURRENCY AND PRICING

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 MULTIVARIATE MODELLING

2.6 DBMR MARKET POSITION GRID

2.7 VENDOR SHARE ANALYSIS

2.8 SECONDARY SOURCES

2.9 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 PREVALENCE OF IGA NEPHROPATHY

4.4 INCIDENCE OF IGA NEPHROPATHY

4.5 CURRENT TREATMENT OF IGA NEPHROPATHY

4.6 EXPENDITURE OF IGA NEPHROPATHY

4.7 DETECTION METHODS OF IGA NEPHROPATHY

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 RISE IN THE NUMBER OF CASES OF IGA NEPHROPATHY

5.1.2 INCREASE IN THE AVAILABILITY OF IGA-TARGETED PIPELINE DRUGS

5.1.3 INCREASING INVESTMENT IN R&D OF DRUG DISCOVERY

5.1.4 INCREASING PRODUCT APPROVALS FOR IGA NEPHROPATHY TREATMENT

5.2 RESTRAINTS

5.2.1 HIGH COST OF IGA NEPHROPATHY TREATMENT

5.2.2 DELAYED DIAGNOSIS OF IGA NEPHROPATHY

5.2.3 POOR PLANNING OF IGA NEPHROPATHY TREATMENT IN LOW-INCOME COUNTRIES

5.2.4 INABILITY TO EFFECTIVELY TREAT IGA NEPHROPATHY

5.3 OPPORTUNITIES

5.3.1 COLLABORATION AMONG MARKET PLAYERS FOR DRUG DEVELOPMENT

5.3.2 INCREASE IN GOVERNMENT FUNDING FOR RESEARCH PURPOSES

5.3.3 INCREASING TREND OF NOVEL DIAGNOSIS PROCEDURE

5.4 CHALLENGES

5.4.1 LOW AWARENESS AMONG THE POPULATION REGARDING KIDNEY DISEASE

5.4.2 STRINGENT GOVERNMENT REGULATIONS RELATED TO THE APPROVAL OF NEUROENDOCRINE TUMOR DRUG

6 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY DISEASE TYPE

6.1 OVERVIEW

6.2 PRIMARY IGA NEPHROPATHY

6.3 SECONDARY IGA NEPHROPATHY

7 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY TYPE

7.1 OVERVIEW

7.2 DIAGNOSIS

7.2.1 URINE TEST

7.2.1.1 URINE ALBUMIN-TO-CREATININE RATIO

7.2.1.2 DIPSTICK TEST FOR ALBUMIN AND BLOOD

7.2.2 BLOOD TEST

7.2.3 IOTHALAMATE CLEARANCE TEST

7.2.4 KIDNEY BIOPSY

7.2.5 OTHERS

7.3 TREATMENT

7.3.1 BLOOD PRESSURE LOWERING AGENTS

7.3.1.1 ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS

7.3.1.1.1 LISINOPRIL

7.3.1.1.2 ENALAPRIL

7.3.1.1.3 RAMIPRIL

7.3.1.1.4 BENAZEPRIL

7.3.1.1.5 OTHERS

7.3.1.2 ANGIOTENSIN RECEPTOR BLOCKERs

7.3.1.2.1 LOSARTAN

7.3.1.2.2 VALSARTAN

7.3.1.2.3 IRBESARTAN

7.3.1.2.4 OTHERS

7.3.2 IMMUNOSUPPRESANT

7.3.2.1 CYCLOPHOSPHAMIDE

7.3.2.2 AZATHIOPRINE

7.3.2.3 CORTICOSTEROIDS

7.3.2.3.1 METHYLPREDNISONE

7.3.2.3.2 PREDNISOLONE

7.3.2.3.3 OTHERS

7.3.2.4 OTHERS

7.3.3 DIURETICS

7.3.3.1 FUROSEMIDE

7.3.3.2 TORSEMIDE

7.3.3.3 BUMETANIDE

7.3.3.4 OTHERS

7.3.4 BLOOD CHOLESTEROL LOWERING AGENTS

7.3.4.1 ATROVASTATIN

7.3.4.2 SIMVASTATIN

7.3.4.3 ROSUVASTATIN

7.3.4.4 FLUVASTATIN

7.3.4.5 PRAVASTATIN

7.3.4.6 OTHERS

7.3.5 SUPPLEMENTS

7.3.5.1 OMEGA-3-FATTY ACIDS

7.3.5.2 VITAMIN E

7.3.5.3 OTHERS

7.3.6 OTHERS

8 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY POPULATION TYPE

8.1 OVERVIEW

8.2 ADULTS

8.3 GERIATRIC

8.4 PEDIATRIC

9 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION

9.1 OVERVIEW

9.2 ORAL

9.2.1 TABLETS/PILLS

9.2.2 CAPSULES

9.2.3 OTHERS

9.3 PARENTERAL

9.3.1 INTRAVENOUS

9.3.2 SUBCUTANEOUS

9.3.3 OTHERS

9.4 OTHERS

10 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY END USER

10.1 OVERVIEW

10.2 HOSPITALS

10.2.1 PRIVATE

10.2.2 PUBLIC

10.3 SPECIALTY CLINICS

10.4 DIAGNOSTIC CENTERS

10.5 AMBULATORY CARE CENTERS

10.6 HOME HEALTHCARE

10.7 OTHERS

11 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 HOSPITAL PHARMACY

11.2.2 ONLINE PHARMACY

11.2.3 RETAIL PHARMACY

11.3 DIRECT TENDER

11.4 OTHERS

12 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM

12.1 MALAYSIA

12.2 THAILAND

12.3 INDONESIA

12.4 PHILIPPINES

12.5 VIETNAM

13 INDONESIA, MALAYSIA, PHILIPPINES, VIETNAM, AND THAILAND IGA NEPHROPATHY MARKET, COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: INDONESIA, MALAYSIA, PHILIPPINES, VIETNAM, AND THAILAND

14 SWOT ANALYSIS

15 COMPANY PROFILE

15.1 SUN PHARMACEUTICAL INDUSTRIES LTD

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 PRODUCT PORTFOLIO

15.1.4 RECENT DEVELOPMENTS

15.3 PFIZER INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 PRODUCT PORTFOLIO

15.3.4 RECENT DEVELOPMENT

15.4 ZYDUS GROUP.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 PRODUCT PORTFOLIO

15.4.4 RECENT DEVELOPMENTS

15.5 NOVARTIS AG

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 PRODUCT PORTFOLIO

15.5.4 RECENT DEVELOPMENTS

15.6 ARKRAY USA, INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 PRODUCT PORTFOLIO

15.6.3 RECENT DEVELOPMENTS

15.7 TEVA PHARMACEUTICAL USA INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE FINANCIALS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENTS

16 QUESTIONNAIRE

17 RELATED REPORTS

List of Table

TABLE 1 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 2 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 3 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 4 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 5 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 6 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 7 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 8 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 9 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 10 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 11 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 12 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 13 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 14 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 15 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 16 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 17 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM PARENTERAL ADMINISTRATION IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 18 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 19 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 20 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 21 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 22 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET, BY REGION, 2022-2034 (USD THOUSAND)

TABLE 23 MALAYSIA IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 24 MALAYSIA IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 25 MALAYSIA DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 26 MALAYSIA URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 27 MALAYSIA TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 28 MALAYSIA BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 29 MALAYSIA ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 30 MALAYSIA ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 31 MALAYSIA IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 32 MALAYSIA CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 33 MALAYSIA DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 34 MALAYSIA BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 35 MALAYSIA SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 36 MALAYSIA IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 37 MALAYSIA IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 38 MALAYSIA ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 39 MALAYSIA PARENTERAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 40 MALAYSIA IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 41 MALAYSIA HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 42 MALAYSIA IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 43 MALAYSIA RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 44 THAILAND IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 45 THAILAND IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 46 THAILAND DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 47 THAILAND URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 48 THAILAND TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 49 THAILAND BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 50 THAILAND ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 51 THAILAND ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 52 THAILAND IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 53 THAILAND CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 54 THAILAND DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 55 THAILAND BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 56 THAILAND SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 57 THAILAND IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 58 THAILAND IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 59 THAILAND ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 60 THAILAND PARENTERAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 61 THAILAND IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 62 THAILAND HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 63 THAILAND IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 64 THAILAND RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 65 INDONESIA IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 66 INDONESIA IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 67 INDONESIA DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 68 INDONESIA URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 69 INDONESIA TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 70 INDONESIA BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 71 INDONESIA ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 72 INDONESIA ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 73 INDONESIA IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 74 INDONESIA CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 75 INDONESIA DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 76 INDONESIA BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 77 INDONESIA SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 78 INDONESIA IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 79 INDONESIA IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 80 INDONESIA ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 81 INDONESIA PARENTERAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 82 INDONESIA IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 83 INDONESIA HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 84 INDONESIA IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 85 INDONESIA RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 86 PHILIPPINES IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 87 PHILIPPINES IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 88 PHILIPPINES DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 89 PHILIPPINES URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 90 PHILIPPINES TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 91 PHILIPPINES BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 92 PHILIPPINES ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 93 PHILIPPINES ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 94 PHILIPPINES IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 95 PHILIPPINES CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 96 PHILIPPINES DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 97 PHILIPPINES BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 98 PHILIPPINES SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 99 PHILIPPINES IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 100 PHILIPPINES IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 101 PHILIPPINES ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 102 PHILIPPINES PARENTERAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 103 PHILIPPINES IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 104 PHILIPPINES HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 105 PHILIPPINES IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 106 PHILIPPINES RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 107 VIETNAM IGA NEPHROPATHY MARKET, BY DISEASE TYPE, 2022-2034 (USD THOUSAND)

TABLE 108 VIETNAM IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 109 VIETNAM DIAGNOSIS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 110 VIETNAM URINE TESTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 111 VIETNAM TREATMENT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 112 VIETNAM BLOOD PRESSURE LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 113 VIETNAM ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 114 VIETNAM ANGIOTENSIN RECEPTOR BLOCKERS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 115 VIETNAM IMMUNOSUPPRESSANT IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 116 VIETNAM CORTICOSTEROIDS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 117 VIETNAM DIURETICS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 118 VIETNAM BLOOD CHOLESTEROL LOWERING AGENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 119 VIETNAM SUPPLEMENTS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 120 VIETNAM IGA NEPHROPATHY MARKET, BY POPULATION TYPE, 2022-2034 (USD THOUSAND)

TABLE 121 VIETNAM IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 122 VIETNAM ORAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 123 VIETNAM PARENTERAL IN IGA NEPHROPATHY MARKET, BY ROUTE OF ADMINISTRATION, 2022-2034 (USD THOUSAND)

TABLE 124 VIETNAM IGA NEPHROPATHY MARKET, BY END USER, 2022-2034 (USD THOUSAND)

TABLE 125 VIETNAM HOSPITALS IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

TABLE 126 VIETNAM IGA NEPHROPATHY MARKET, BY DISTRIBUTION CHANNEL, 2022-2034 (USD THOUSAND)

TABLE 127 VIETNAM RETAIL SALES IN IGA NEPHROPATHY MARKET, BY TYPE, 2022-2034 (USD THOUSAND)

List of Figure

FIGURE 1 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: SEGMENTATION

FIGURE 2 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: DATA TRIANGULATION

FIGURE 3 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: DROC ANALYSIS

FIGURE 4 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: MULTIVARIATE MODELLING

FIGURE 7 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: DBMR MARKET POSITION GRID

FIGURE 8 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: VENDOR SHARE ANALYSIS

FIGURE 9 INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM IGA NEPHROPATHY MARKET: SEGMENTATION

FIGURE 10 RISE IN IGA NEPHROPATHY DISORDER IS DRIVING THE INDONESIA, MALAYSIA, THAILAND, PHILIPPINES, AND VIETNAM, IGA NEPHROPATHY MARKET IN THE FORECAST PERIOD OF 2024 TO 2034

FIGURE 11 PRIMARY IGA NEPHROPATHY IS EXPECTED TO ACCOUNT FOR LARGEST SHARE IN THE TYPE SEGEMENT

FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET

FIGURE 13 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISEASE TYPE, 2023

FIGURE 14 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISEASE TYPE, 2024-2034 (USD THOUSAND)

FIGURE 15 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISEASE TYPE, CAGR (2024-2031)

FIGURE 16 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISEASE TYPE, LIFELINE CURVE

FIGURE 17 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY TYPE, 2023

FIGURE 18 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY TYPE, 2023-2034 (USD THOUSAND)

FIGURE 19 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY TYPE, CAGR (2023-2034)

FIGURE 20 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY TYPE, LIFELINE CURVE

FIGURE 21 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY POPULATION TYPE, 2023

FIGURE 22 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY POPULATION TYPE, 2024-2034 (USD THOUSAND)

FIGURE 23 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY POPULATION TYPE, CAGR (2024-2034)

FIGURE 24 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 25 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY ROUTE OF ADMINISTRATION, 2023

FIGURE 26 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY ROUTE OFADMINISTRATION, 2024-2034 (USD THOUSAND)

FIGURE 27 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2034)

FIGURE 28 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY END USER, 2023

FIGURE 30 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY END USER, 2024-2034 (USD THOUSAND)

FIGURE 31 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY END USER, CAGR (2024-2034)

FIGURE 32 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 34 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISTRIBUTION CHANNEL, 2024-2034 (USD THOUSAND)

FIGURE 35 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2034)

FIGURE 36 INDONESIA, MALAYSIA, PHILIPPINES, THAILAND AND VIETNAM IGA NEPHROPATHY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 INDONESIA, MALAYSIA, PHILIPPINES, VIETNAM AND THAILAND IGA NEPHROPATHY MARKET: COMPANY SHARE 2023 (%)

Frequently Asked Questions

The market is segmented based on Indonesia, Malaysia, Thailand, Philippines and Vietnam IgA Nephropathy Market, By Disease Type (Primary IgA Nephropathy and Secondary IgA Nephropathy), Type (Diagnosis and Treatment), Population Type (Adults, Geriatric, and Pediatric), Route of Administration (Oral, Parenteral, and Others), End User (Hospitals, Specialty Clinics, Diagnostic Centers, Ambulatory Care Centers, Home Healthcare, and Others), Distribution Channel (Retail Sales, Direct Tenders, and Others) - Industry Trends and Forecast to 2034. .
The Indonesia Malaysia Philippines Thailand And Vietnam Iga Nephropathy Market size was valued at USD 15716.44 USD million in 2023.
The Indonesia Malaysia Philippines Thailand And Vietnam Iga Nephropathy Market is projected to grow at a CAGR of 10.1% during the forecast period of 2024 to 2034.
The market report covers data from the Indonesia, Malaysia, Philippines, Thailand, and Vietnam.

Browse Related Pages

Banner